Zosano Presents Early-Onset of Action Data for Qtrypta™ in Migraine

 

• Review of data from the ZOTRIP trial suggest that Qtrypta showed therapeutic gain at 30 minutes consistent with recently published criteria for evaluating early onset of action
  
  
• All Qtrypta patients who were pain free at 30 minutes were still pain free at 2 hours
  
  
• Observation of pain freedom at 30 minutes was more accurate than the observation of relief at 30 minutes in predicting pain freedom at 2 hours

https://www.globenewswire.com/news-release/2021/02/01/2167325/0/en/Zosano-Pharma-Presents-Early-Onset-of-Action-Data-for-Qtrypta-in-Acute-Treatment-of-Migraines.html